Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Galapagos provides update on arthritis alliance with GSK

Jan. 18, 2011

Epizyme and GSK join to develop agents targeting histone methyltransferases

Jan. 18, 2011

Lilly and Boehringer Ingelheim enter global diabetes alliance

Jan. 18, 2011

Dyax and Sigma-Tau expand agreement to commercialize Kalbitor

Jan. 17, 2011

Celtic Therapeutics acquires RX-10045 from Resolvyx Pharma

Jan. 17, 2011

AstraZeneca and SCRI join to develop targeted anticancer agent

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Jan. 12, 2011

Immutep and GSK enter into agreement for ImmuTune IMP-731

Jan. 12, 2011

Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan

Jan. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...